TAS::75 0872::TAS BIOMEDICAL (APPLID/EXPLORATORY) 8010562

塔斯::75 0872::塔斯生物医学（应用/探索）8010562

• 批准号: 8354977
• 负责人: YANGFENG WU
• 金额: $ 50.83万
• 依托单位: GEORGE INSTITUTE CHINA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-06-08 至 2014-06-07
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8354977
• 关键词: Cardiovascular system; China; Collaborations; Community Healthcare; Diuretics; Funding; Guidelines; Health Personnel; India; Individual; Institutes; Patients; Primary Health Care; Provider; Resources; Testing; Tibet; base; cost; high risk; programs; secondary outcome

The George Institute has applied for supplemental funding in order to develop, pilot test, and evaluate a highly simplified but guideline-based program for cardiovascular management in resource-scarce settings. The specific aim is to evaluate the effects of implementing a simple low-cost cardiovascular management program for high-risk individuals, delivered by primary care providers and community healthcare workers (CHWs), on the proportion of patients appropriately treated with diuretics as well as a number of secondary outcomes. The program will be conducted in Tibet, China and Haryana, India and it is collaboration between the China and India-Delhi COEs.

乔治研究所已经申请了补充资金，以开发、试点测试和评估一个高度简化但基于指南的项目，用于资源稀缺环境下的心血管管理。具体目的是评估由初级保健提供者和社区卫生保健工作者（CHWs）提供的对高危人群实施简单低成本心血管管理方案对适当使用利尿剂治疗的患者比例以及一些次要结局的影响。